The ultimate goal of current and future biomarkers in rheumatic diseases is to enable early detection of these diseases and their clinical manifestations. PubMed, BMJ, 2015 Nov 26;351:h5079. (Also see Biomarkers)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.